Xanthophyll β‐Cryptoxanthin Inhibits Highly Refined Carbohydrate Diet–Promoted Hepatocellular Carcinoma Progression in Mice. Issue 3 (9th January 2020)

• Record Type: Journal Article
• Authors: Lim, Ji Ye; Liu, Chun; Hu, Kang‐Quan; Smith, Donald E.; Wu, Dayong; Lamon‐Fava, Stefania; Ausman, Lynne M.; Wang, Xiang‐Dong
• Is Part Of: Molecular nutrition & food research. Volume 64:Issue 3(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-01-09
• Subjects: β‐Cryptoxanthin -- carotenoid cleavage enzymes -- glucose metabolism -- hepatocellular carcinoma -- highly refined carbohydrate diets; Food -- Biotechnology -- Periodicals; Food -- Microbiology -- Periodicals; Nutrition -- Periodicals; Food -- Toxicology -- Periodicals; Nutrition -- Periodicals; Food Microbiology -- Periodicals; Food Technology -- Periodicals; Molecular Biology -- Periodicals; 664.0705
• DOI: 10.1002/mnfr.201900949
• Languages: English
• ISSNs: 1613-4125

Abstract

Abstract : Scope: β‐Cryptoxanthin (BCX) can be cleaved by both β‐carotene 15, 15′‐oxygenase (BCO1) and β‐carotene 9′, 10′‐oxygenase (BCO2), generating biological active vitamin A and apocarotenoids. We examined whether BCX feeding could inhibit diethylnitrosamine (DEN)‐initiated, highly refined carbohydrate diet (HRCD)‐promoted hepatocellular carcinoma (HCC) development, dependent or independent of BCO1/BCO2 activity. Methods and results: Two‐week‐old male wild‐type (WT) and BCO1 −/− /BCO2 −/− double knockout (DKO) mice are given a single intraperitoneal injection of DEN (25 mg kg −1 body weight) to initiate hepatic carcinogenesis. At 6 weeks of age, all animals are fed HRCD (66.5% of energy from carbohydrate) with or without BCX for 24 weeks. BCX feeding increases hepatic vitamin A levels in WT mice, but not in DKO mice that shows a significant accumulation of hepatic BCX. Compared to their respective HRCD littermates, both WT and DKO fed BCX have significantly lower HCC multiplicity, average tumor size, and total tumor volume, and the steatosis scores. The chemopreventive effects of BCX are associated with increased p53 protein acetylation and decreased protein levels of lactate dehydrogenase and hypoxia‐inducible factor‐1α in tumors. Conclusion: This study suggests that BCX feeding may alleviate HRCD‐promoted HCC progression by modulating the acetylation of p53, hypoxic tumor microenvironment, and glucose metabolism, independent of BCO1/BCO2. Abstract : This study demonstrates that dietary provitamin A carotenoid β‐cryptoxanthin inhibits highly refined carbohydrate diet–promoted hepatocellular carcinoma progression, which is associated with increased tumor suppressor p53 function and altered glucose metabolism in tumors. The chemopreventive effect of β‐cryptoxanthin is effective in the presence or absence of carotenoid cleavage enzymes, indicating the β‐cryptoxanthin molecule itself having a unique biological function.